{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:21:49Z","timestamp":1648657309744},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,7,15]]},"DOI":"10.2169\/internalmedicine.0416-17","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T22:18:25Z","timestamp":1519769905000},"page":"2007-2011","source":"Crossref","is-referenced-by-count":0,"title":["An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease"],"prefix":"10.2169","volume":"57","author":[{"given":"Masami","family":"Miki","sequence":"first","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kawabe","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ohishi","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Fukuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Karashima","sequence":"additional","affiliation":[{"name":"Department of Urology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Urology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Urology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhide","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Lonser RR, Glenn GM, Walther M, et al. Von Hippel-Lindau disease. Lancet 361: 2059-2067, 2003.","DOI":"10.1016\/S0140-6736(03)13643-4"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Kulke MH, Anthony LB, Bushnell DL, de Herder WW, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39: 735-752, 2010.","DOI":"10.1097\/MPA.0b013e3181ebb168"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Igarashi H, Ito T, Nishimori I, et al. Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey. J Gastroenterol 49: 511-516, 2014.","DOI":"10.1007\/s00535-013-0794-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ito T, Igarashi H, Kazuhiko K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50: 58-64, 2015.","DOI":"10.1007\/s00535-014-0934-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maddock IR, Moran A, Maher ER, et al. A genetic register for von Hippel-Lindau disease. Genet 33: 120-127, 1996.","DOI":"10.1136\/jmg.33.2.120"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Richard S, Campello C, Taillandier L, Parker F, Resche F. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med 243: 547-553, 1998.","DOI":"10.1046\/j.1365-2796.1998.00337.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Blansfield JA, Choyke L, Morita SY, et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 142: 814-818, 2007.","DOI":"10.1016\/j.surg.2007.09.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Charlesworth M, Verbeke CS, Falk GA, Walsh M, Smith AM, Morris-Stiff G. Pancreatic lesions in von Hippel-Lindau disease? a systematic review and meta-synthesis of the literature. J Gastrointest Surg 16: 1422-1428, 2012.","DOI":"10.1007\/s11605-012-1847-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Erlic Z, Ploeckinger U, Cascon A, et al. Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer 17: 875-883, 2010.","DOI":"10.1677\/ERC-10-0037"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Yamasaki I, Nishimori I, Ashida S, Kohsaki T, Onishi S, Shuin T. Clinical characteristics of pancreatic neuroendocrine tumors in Japanese patients with von Hippel-Lindau disease. Pancreas 33: 382-385, 2006.","DOI":"10.1097\/01.mpa.0000240604.26312.e4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ali T, Kandil D, Piperdi B. Long-term disease control with sunitinib in a patient with metastatic pancreatic neuroendocrine tumor (NET) associated with Von Hippel-Lindau syndrome (VHL) To. Pancreas 41: 492-493, 2012.","DOI":"10.1097\/MPA.0b013e31822a645e"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tang LH, Basturk O, Sue JJ, Klimstra DS. A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas. Am J Surg Pathol 40: 1192-1202, 2016.","DOI":"10.1097\/PAS.0000000000000662"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. V\u00e9layoudom-C\u00e9phise FL, Duvillard P, Foucan L, et al. Are G3 ENETS neuroendocrine neoplasms heterogeneous? Endocr Relat Cancer 20: 649-657, 2013.","DOI":"10.1530\/ERC-13-0027"},{"key":"14","unstructured":"14. Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J. Who Classification of Tumours of Endocrine Organs (World Health Organization Classification of Tumours). 4th ed. IARC, Lyon, 2017."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Ann Oncol 24: 152-160, 2013.","DOI":"10.1093\/annonc\/mds276"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hijioka S, Hosoda W, Mizuno N, et al. Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas? J Gastroenterol 50: 564-572, 2015.","DOI":"10.1007\/s00535-014-0987-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors for the RAD001 in advanced neuroendocrine tumors, third trial (RADIANT-3) study group. N Engl J Med 364: 514-523, 2011.","DOI":"10.1056\/NEJMoa1009290"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Panzuto F, Rinzivillo M, Spada F, et al. Everolimus in pancreatic neuroendocrine carcinomas G3. Pancreas 46: 302-305, 2017.","DOI":"10.1097\/MPA.0000000000000762"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364: 501-513, 2011.","DOI":"10.1056\/NEJMoa1003825"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Speisky D, Duces A, Bi\u00e8che I, et al. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and von Hippel-Lindau patients. Clin Cancer Res 18: 2838-2849, 2012.","DOI":"10.1158\/1078-0432.CCR-11-2759"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Aoki T, Kokudo N, Komoto I, et al. Streptozocin chemotherapy for advanced\/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan. J Gastroenterol 50: 769-775, 2015.","DOI":"10.1007\/s00535-014-1006-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/14\/57_0416-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:03:15Z","timestamp":1570838595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/14\/57_0416-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,15]]},"references-count":21,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0416-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,15]]}}}